HELP Stock Slides As Suicide Attempt Overshadows Strong Late-stage Depression Trial Data
Shares of Helus Pharma (HELP) fell about 12% on Monday after the company disclosed a suicide attempt in its late-stage trial of depression drug HLP003, though executives said they observed no suicidality signal for the drug.The company said that there were three treatment-related serious adverse ev…